"Alrijne Ziekenhuis Leiden is een sfeervol en overzichtelijk stadsziekenhuis voor de inwoners van Leiden en omstreken en de Duin- en Bollenstreek. Voor spoedeisende en complexe klinische zorg gaat u naar Alrijne Leiderdorp."

During the past decade, Diaconessenhuis Leiden conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Diaconessenhuis Leiden" #1 sponsor was "Ipsen" with 3 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored, "Academisch Ziekenhuis Maastricht" with 1 trials sponsored, "Erasme University Hospital" with 1 trials sponsored and "Ferring Pharmaceuticals" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Diaconessenhuis Leiden" #1 collaborator was "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator, "BioInvent International AB" with 1 trials as a collaborator, "Borstkanker Onderzoek Groep" with 1 trials as a collaborator, "Comprehensive Cancer Centre The Netherlands" with 1 trials as a collaborator and "Gastrostart" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Diaconessenhuis Leiden" are "Prostate Cancer" (3 trials), "Lymphoma" (2 trials), "Advanced Prostate Cancer" (1 trials), "Breast Cancer" (1 trials) and "Cardiovascular Diseases" (1 trials). Many other conditions were trialed in "Diaconessenhuis Leiden" in a lesser frequency.

Most popular intervention types in "Diaconessenhuis Leiden" are "Drug" (7 trials), "Biological" (3 trials), "Procedure" (3 trials), "Other" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Triptorelin (Decapeptyl®)" (2 trials), "prednisone" (2 trials), "ABVD regimen" (1 trials), "BEACOPP regimen" (1 trials) and "CHOP regimen" (1 trials). Other intervention names were less common.

The vast majority of trials in "Diaconessenhuis Leiden" are 8 trials for "All" genders, 4 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Diaconessenhuis Leiden". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Diaconessenhuis Leiden, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Diaconessenhuis Leiden, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".